Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.44 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.44 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.44 |
| ▸ | BID | P55957 | 3/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.41 |
| ▸ | PPARA | Q07869 | 3/20 | 0.41 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.41 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.41 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.41 |
| ▸ | PPARG | P37231 | 2/20 | 0.41 |
| ▸ | EP300 | Q09472 | 1/20 | 0.41 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.41 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.41 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.41 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.39 |
| ▸ | CTRC | Q99895 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11776421 | 0.98 | LIPG (0.47) | LIPGNR1H2NR1H3BIDMCL1 | |
| Bromide SCHEMBL29257750 | 0.96 | LIPG (0.46) | LIPGNR1H2NR1H3BIDMCL1 | |
| SCHEMBL28413724 | 0.94 | CTRC (0.43) | LIPGNR1H2NR1H3BIDMCL1 | |
| SCHEMBL29194801 | 0.92 | LIPG (0.42) | LIPGNR1H2NR1H3BIDMCL1 | |
| SCHEMBL10425151 | 0.86 | ELANE (0.39) | MAPTALDH1A1POLBHTTL3MBTL1 | |
| SCHEMBL981305 | 0.80 | — | — | |
| SCHEMBL30195050 | 0.76 | SMN1; SMN2 (0.42) | BIDMCL1BCL2L1BAK1MAPT | |
| SCHEMBL4054834 | 0.76 | SRC (0.39) | LIPGNR1H2NR1H3MAPTCTRC | |
| SCHEMBL16823391 | 0.73 | CA1 (0.44) | MAPTCTRCALDH1A1POLBHTT | |
| SCHEMBL11912452 | 0.73 | LIPG (0.47) | LIPGNR1H2NR1H3BIDMCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4117451-A1 | PROCESS FOR PRODUCING AN AROMA-LADEN GAS, AROMA-LADEN GAS AND USE OF THE AROMA-LADEN GAS | Döhler GmbH (DE) | 2023-01-18 | — | — | EP | claimed |
| CN-109535174-A | A kind of two sulphur pyrrolones of N- aryl-pyranone hybrid derivatives and its preparation method and application | 桂林医学院 | 2019-03-29 | — | — | CN | claimed |
| EP-4243619-A1 | CITRUS OIL EXTRACT | Firmenich SA (CH) | 2023-09-20 | — | — | EP | disclosed |
| WO-2022101424-A1 | CITRUS OIL EXTRACT | FIRMENICH SA (CH) | 2022-05-19 | — | — | WO | disclosed |
| US-20210340121-A1 | SUBSTITUTED PYRIDINE AND PYRIMIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2021-11-04 | — | — | US | disclosed |
| US-11062794-B2 | Olfactory signature and odorant mixture having the same | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2021-07-13 | — | — | US | disclosed |
| US-11008302-B2 | Substituted pyridine and pyrimidines and their use as GluN2B receptor modulators | JANSSEN PHARMACEUTICA NV (BE) | 2021-05-18 | — | — | US | disclosed |
| CN-112481326-A | Method for producing 6-pentyl-2H-pyran-2-one by virtue of loss fermentation | 宜宾五粮液股份有限公司 | 2021-03-12 | — | — | CN | disclosed |
| EP-3774732-A2 | SUBSTITUTED PYRIDINE AND PYRIMIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | Janssen Pharmaceutica NV (BE) | 2021-02-17 | — | — | EP | disclosed |
| US-20190308950-A1 | SUBSTITUTED PYRIDINE AND PYRIMIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2019-10-10 | — | — | US | disclosed |
| WO-2019193516-A2 | SUBSTITUTED PYRIDINE AND PYRIMIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2019-10-10 | — | — | WO | disclosed |
| CN-109535174-A | A kind of two sulphur pyrrolones of N- aryl-pyranone hybrid derivatives and its preparation method and application | 桂林医学院 | 2019-03-29 | — | — | CN | disclosed |
| US-20180253534-A1 | OLFACTORY SIGNATURE AND ODORANT MIXTURE HAVING THE SAME | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2018-09-06 | — | — | US | disclosed |
| US-9959392-B2 | Olfactory signature and odorant mixture having the same | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2018-05-01 | — | — | US | disclosed |
| US-20140221269-A1 | OLFACTORY SIGNATURE AND ODORANT MIXTURE HAVING THE SAME | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2014-08-07 | — | — | US | disclosed |
| EP-2735607-A1 | Strain of Trichoderma harzianum and controlled release composition which contains said strain | SC Corx Bioneer Ceu SA (RO) | 2014-05-28 | — | — | EP | disclosed |
| WO-2013035070-A1 | OLFACTORY SIGNATURE AND ODORANT MIXTURE HAVING THE SAME | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2013-03-14 | — | — | WO | disclosed |
| WO-2001051481-A1 | METHOD FOR THE SYNTHESIS OF 6N-PENTYL-2H-PYRAN-2-ONE | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2001-07-19 | — | — | WO | disclosed |
| EP-0588137-B1 | 3-Aryl-2-pyranone derivatives | BAYER AG (DE) | 1999-02-03 | — | — | EP | disclosed |
| EP-0588137-A1 | 3-Aryl-2-pyranone derivatives | BAYER AG (DE) | 1994-03-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190308950-A1 | SUBSTITUTED PYRIDINE AND PYRIMIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | GRIN2B, GRIN2A, GRIN3B | LIPG 4764/4885NR1H2 557/4885NR1H3 671/4885 |
| US-20210340121-A1 | SUBSTITUTED PYRIDINE AND PYRIMIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | GRIN2B, GRIN2A, GRIN3B | LIPG 4764/4885NR1H2 557/4885NR1H3 671/4885 |
| US-11008302-B2 | Substituted pyridine and pyrimidines and their use as GluN2B receptor modulators | GRIN2B, GRIN2A, GRIN3B | LIPG 4785/4885NR1H2 499/4885NR1H3 598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.